GBS: Measuring Glucose in Saliva

article image

GBS has an innovative printable biosensor platform technology that can measure glucose in saliva and the company believes it could be a game changer for people with diabetes, perhaps one day making blood glucose finger-sticks obsolete.

People with diabetes face a daily healthcare burden that can be overwhelming at times. To maintain optimal blood sugar levels, they need to regularly track their blood glucose, keep a log of their meals and exercise, and those on insulin must calculate and administer appropriate doses—all of which they must manage largely on their own. But diabetes also is the target of a great deal of medtech innovation aimed at making glucose management easier and more effective.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: